This is a Validated Antibody Database (VAD) review about mouse Tnfrsf9, based on 14 published articles (read how Labome selects the articles), using Tnfrsf9 antibody in all methods. It is aimed to help Labome visitors find the most suited Tnfrsf9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Tnfrsf9 synonym: 4-1BB; A930040I11Rik; AA408498; AI325004; CDw137; Cd137; ILA; Ly63

BioLegend
rat monoclonal (TKS-1)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Tnfrsf9 antibody (BioLegend, TKS-1) was used in flow cytometry on mouse samples at 1:200. J Immunother Cancer (2021) ncbi
rat monoclonal (TKS-1)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Tnfrsf9 antibody (Biolegend, 107105) was used in flow cytometry on mouse samples (fig 2c). Nat Commun (2021) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; loading ...; fig s3m
BioLegend Tnfrsf9 antibody (BioLegend, 17-B5) was used in flow cytometry on mouse samples (fig s3m). Science (2019) ncbi
rat monoclonal (TKS-1)
  • flow cytometry; mouse; loading ...; fig s15d
BioLegend Tnfrsf9 antibody (Biolegend, TKS-1) was used in flow cytometry on mouse samples (fig s15d). Science (2019) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; loading ...; fig s16b
BioLegend Tnfrsf9 antibody (Biolegend, 17B5) was used in flow cytometry on mouse samples (fig s16b). Science (2019) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; 1:400; loading ...; fig ex4f
BioLegend Tnfrsf9 antibody (BioLegend, 17B5) was used in flow cytometry on mouse samples at 1:400 (fig ex4f). Nat Med (2019) ncbi
rat monoclonal (TKS-1)
BioLegend Tnfrsf9 antibody (BioLegend, 107105) was used . PLoS ONE (2016) ncbi
rat monoclonal (TKS-1)
  • flow cytometry; mouse; fig 1
BioLegend Tnfrsf9 antibody (Biolegend, TKS-1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2016) ncbi
Invitrogen
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen Tnfrsf9 antibody (eBioscience, 12-1371-82) was used in flow cytometry on mouse samples (fig 3e). elife (2020) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; fig s2f
Invitrogen Tnfrsf9 antibody (eBiosciences, 12-1371-81) was used in flow cytometry on mouse samples (fig s2f). Cell (2018) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse
Invitrogen Tnfrsf9 antibody (eBioscience, 17B5) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; fig 2
In order to characterize and compare T helper 1 and 17 cells, Invitrogen Tnfrsf9 antibody (eBiosciences, 17B5) was used in flow cytometry on mouse samples (fig 2). J Leukoc Biol (2007) ncbi
Syrian golden hamster monoclonal (17B5)
  • flow cytometry; mouse; fig 1
In order to report that 4-1BB costimulator receptor induces the proliferation of the CD4+CD25+ regulatory T cells, Invitrogen Tnfrsf9 antibody (eBioscience, 17B5) was used in flow cytometry on mouse samples (fig 1). J Immunol (2004) ncbi
Bio X Cell
rat monoclonal (LOB12.3)
  • blocking or activating experiments; mouse; fig 5d
Bio X Cell Tnfrsf9 antibody (BioXcell, LOB12.3) was used in blocking or activating experiments on mouse samples (fig 5d). elife (2020) ncbi
BD Biosciences
rat monoclonal (1AH2)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, BD Biosciences Tnfrsf9 antibody (BD Biosciences, 1AH2) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
Articles Reviewed
  1. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  2. Khaw Y, Majid D, Oh S, Kang E, Inoue M. Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling. Nat Commun. 2021;12:105 pubmed publisher
  3. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  4. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  5. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  6. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  7. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  8. Rajbhandari P, Thomas B, Feng A, Hong C, Wang J, Vergnes L, et al. IL-10 Signaling Remodels Adipose Chromatin Architecture to Limit Thermogenesis and Energy Expenditure. Cell. 2018;172:218-233.e17 pubmed publisher
  9. Martin S, Brown S, Wick D, Nielsen J, Kroeger D, Twumasi Boateng K, et al. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines. PLoS ONE. 2016;11:e0155189 pubmed publisher
  10. Lee Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, et al. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol. 2016;196:3385-97 pubmed publisher
  11. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  12. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed publisher
  13. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  14. Zheng G, Wang B, Chen A. The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J Immunol. 2004;173:2428-34 pubmed